Cargando…

Editorial: Infection-Related Rheumatic Diseases

Detalles Bibliográficos
Autores principales:	Thomas, Konstantinos, Calabrese, Cassandra, Vassilopoulos, Dimitrios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568794/ https://www.ncbi.nlm.nih.gov/pubmed/34746198 http://dx.doi.org/10.3389/fmed.2021.779773

Ejemplares similares

Editorial: Rheumatic Diseases and Infection
por: Dong, Lingli, et al.
Publicado: (2022)

Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations
por: Koutsianas, Christos, et al.
Publicado: (2020)

Editorial: Innovation in Rheumatic Diseases
por: Jacinto, Maria João, et al.
Publicado: (2022)

Editorial: Comorbidity Burden in Rheumatic Diseases
por: Nikiphorou, Elena, et al.
Publicado: (2018)

Editorial: Nutrition and Metabolism in Rheumatic Diseases
por: Canhao, Helena, et al.
Publicado: (2019)

Editorial: Osteoporosis in Rheumatic Diseases, What's New?
por: Ruaro, Barbara, et al.
Publicado: (2021)

Editorial: Molecular markers in rheumatic diseases and their comorbidities
por: Vazquez-Del Mercado, Monica, et al.
Publicado: (2023)

Editorial: Drug Survival: Treatment of Rheumatic Diseases in the Biologic Era
por: Di Sanzo, Lorenzo, et al.
Publicado: (2022)

Editorial: Psychological impact and quality of life in rheumatic and musculoskeletal diseases
por: Talarico, Rosaria, et al.
Publicado: (2023)

Editorial: Multidisciplinary approach to interstitial lung disease associated with systemic rheumatic diseases
por: Sambataro, Gianluca, et al.
Publicado: (2022)

Editorial: Advance in B-cell therapies for the treatment of rheumatic and musculoskeletal diseases
por: Md Yusof, Md Yuzaiful, et al.
Publicado: (2022)

Editorial: Omics for the objective diagnosis and management of immune-mediated rheumatic diseases
por: Fu, Tieh-Cheng, et al.
Publicado: (2023)

Editorial: Chronic rheumatic inflammatory conditions and cardiovascular health
por: Lo Gullo, Alberto, et al.
Publicado: (2022)

Editorial: Novel biomarkers for clinical and molecular stratification of organ involvement in rheumatic diseases
por: Sun, Xiaolin, et al.
Publicado: (2023)

Patients’ and Doctors’ Beliefs about Treatment and Long-Term Adherence in Rheumatic Diseases
por: Yfantopoulos, John, et al.
Publicado: (2020)

IL-33 in Rheumatic Diseases
por: Dong, Yuanji, et al.
Publicado: (2021)

Immunomics in Pediatric Rheumatic Diseases
por: Tay, Shi Huan, et al.
Publicado: (2019)

Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes
por: Kastritis, Efstathios, et al.
Publicado: (2020)

Infections in the Era of Targeted Therapies: Mapping the Road Ahead
por: Calabrese, Leonard H., et al.
Publicado: (2020)

Editorial: Rheumatic fever: 21st century clinical and experimental insights
por: Nascimento, Bruno R., et al.
Publicado: (2023)

Rheumatic Fever and Rheumatic Heart Disease a Historical Perspective
por: Hajar, Rachel
Publicado: (2016)

Infections in Patients with Rheumatoid Arthritis in the Era of Targeted Synthetic Therapies
por: Thomas, Konstantinos, et al.
Publicado: (2020)

Novel Surrogate Markers of Cardiovascular Risk in the Setting of Autoimmune Rheumatic Diseases: Current Data and Implications for the Future
por: Mandel, Anna, et al.
Publicado: (2022)

Real Life Efficacy and Safety of Secukinumab in Biologic-Experienced Patients With Psoriatic Arthritis
por: Klavdianou, Kalliopi, et al.
Publicado: (2020)

Cardiovascular Imaging Techniques in Systemic Rheumatic Diseases
por: Atzeni, Fabiola, et al.
Publicado: (2018)

Editorial: Frontiers in Autoimmune Disease: Rheumatic Fever and Rheumatic Heart Disease
por: Guilherme, Luiza, et al.
Publicado: (2015)

Conversion and Reversion Rates of Tuberculosis Screening Assays in Patients With Rheumatic Diseases and Negative Baseline Screening Under Long-Term Biologic Treatment
por: Thomas, Konstantinos, et al.
Publicado: (2020)

Exercise, infection and rheumatic diseases: what do we know?
por: Calabrese, Leonard, et al.
Publicado: (2021)

The Therapeutic Role of Interleukin-1 Inhibition in Idiopathic Recurrent Pericarditis: Current Evidence and Future Challenges
por: Lazaros, George, et al.
Publicado: (2017)

Acute Rheumatism and Pneumonia
Publicado: (1908)

Current State and Issues of Regenerative Medicine for Rheumatic Diseases
por: Yoshimi, Ryusuke, et al.
Publicado: (2022)

COVID-19 and rheumatic diseases: A mini-review
por: Roseti, Livia, et al.
Publicado: (2022)

For patients with rheumatic disease and hepatitis C infection: the end of interferon
por: Calabrese, Leonard H, et al.
Publicado: (2015)

Rheumatic?—A Digital Diagnostic Decision Support Tool for Individuals Suspecting Rheumatic Diseases: A Multicenter Pilot Validation Study
por: Knevel, Rachel, et al.
Publicado: (2022)

The rise and fall of acute rheumatic fever and rheumatic heart disease: a mini review
por: Liang, Yunmei, et al.
Publicado: (2023)

Incidence of serious infections in patients with ANCA-associated vasculitis receiving immunosuppressive therapy: A systematic review and meta-analysis
por: Vassilopoulos, Athanasios, et al.
Publicado: (2023)

Infections as a cause of autoimmune rheumatic diseases
por: Sakkas, Lazaros I., et al.
Publicado: (2016)

Interstitial Lung Disease Associated With Autoimmune Rheumatic Diseases: Checklists for Clinical Practice
por: Bosello, Silvia Laura, et al.
Publicado: (2021)

Neoplasm Risk in Rheumatic Diseases Has No Correlation With Conventional Synthetic Disease-Modifying Anti-rheumatic Drugs Usage—A Population-Based Nested Case–Control Study
por: Cai, Shaozhe, et al.
Publicado: (2020)

Protective Role of Rheumatic Diseases Against Hepatitis B Virus Infection and Human Leukocyte Antigen B27 Highlighted
por: Ye, Junna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k0oqi44nd6iscis8vp3msbe6gu